Resources for Doctors >>

- Announce state-of-the-art assays available from OncQuest.
- Explore recent advances in diagnosis, prognosis, monitoring and clinical applications.
- Survey the current literature and provide a representative bibliography.

These are:

• CMLQuest - D (BCR/ABL translocation t (9; 22) for diagnosis)

• CMLQuest - MRD (BCR/ABL translocation t (9; 22) for Minimal Residual Disease)

• APLQuest - D (PML/RARa translocation t (15; 17) for diagnosis)

• APL Quest - MRD (PML/RARa translocation t (15; 17) for Minimal Residual Disease)

• neuQuest (Her2/ Neu gene amplification)

• C-mycQuest (C-myc gene amplification)

• QuestEGFR  - GA (EGFR gene amplification)

• Quest EGFR  - O (EGFR mRNA overexpression)

• Quest Cyclin D1 (Cyclin D1 gene amplification)

• B cell Clonality Analysis

• DNA Ploidy and S-Phase Estimation

• Imunophenotyping of Leukemias/ Lymphomas

• Chromosomal Karyotyping for Cancer

• Fluorescent In Situ Hybridization

• Flit 3 Mutation by PCR

• ComboQuest Panels

• CML Quest - BPA (BCR/abl with Break Point Analysis)

• CML Quest - IRMA (BCR/abl with Imatinib Resistance Mutation Analysis)

• MPD Quest (JAK2 Mutation Analysis for Myeloproliferative disorders)

• Quest PDGFRa ( FIP1L1-PDGFRa Mutation for Hypereosinophilic syndrome HES, Chronic eosinophilic leukemia (CEL) Systemic Mast Cell Disorder-eos (SMCD-eos)

Top

--------------------------------------------------------
© 2004, OncQuest Laboratories PVT. LTD. All rights reserved. Disclaimer
3, Factory Road, Adj. Safdarjung Hospital, New Delhi - 110 029, INDIA.
Tel: +91-11-26101240; Facsimile: +91-11-26182231; Email: marketingserv@daburpharma.com
Help Line:  1 901 441 441

Site designed and developed by Netcomm Labs